Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2026-06-10 21:09:17 ET · period of report 2026-05-21 · accession 0001543174-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-10 21:09 | 2026-05-21 | ANIP | TANNENBAUM RENEE P | Dir | A - Grant | $0.00 | +4,357 | 29.5K | +17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-21 | A | A | 4,357 | $0.00 | 29,514 | D | — | — | (F1) Represents a restricted stock award that will vest in full on May 21, 2027. |